2022 Q2 Form 10-Q Financial Statement

#000158370822000042 Filed on June 01, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q2
Revenue $78.26M $65.64M $37.40M
YoY Change 109.27% 119.75% 108.25%
Cost Of Revenue $27.14M $24.25M $18.28M
YoY Change 48.44% 75.27% 140.15%
Gross Profit $51.12M $41.39M $19.11M
YoY Change 167.46% 158.14% 84.76%
Gross Profit Margin 65.32% 63.06% 51.11%
Selling, General & Admin $95.53M $69.83M $52.90M
YoY Change 80.57% 112.27% 132.98%
% of Gross Profit 186.89% 168.73% 276.81%
Research & Development $45.88M $42.64M $27.82M
YoY Change 64.92% 111.11% 100.65%
% of Gross Profit 89.76% 103.04% 145.56%
Depreciation & Amortization $2.102M $2.047M $1.659M
YoY Change 26.7% -7.29% -100.02%
% of Gross Profit 4.11% 4.95% 8.68%
Operating Expenses $141.4M $112.5M $80.72M
YoY Change 75.18% 111.92% 120.72%
Operating Profit -$90.30M -$71.09M -$61.61M
YoY Change 46.56% 91.91% 134.9%
Interest Expense $5.000K $57.00K $303.0K
YoY Change -98.35% -119.86% -302.0%
% of Operating Profit
Other Income/Expense, Net -$291.0K -$259.0K -$593.0K
YoY Change -50.93% -14.24% 207.25%
Pretax Income -$89.51M -$71.29M -$62.49M
YoY Change 43.24% 89.45% 135.15%
Income Tax $329.0K $416.0K $149.0K
% Of Pretax Income
Net Earnings -$89.83M -$71.71M -$62.63M
YoY Change 43.43% 89.5% 135.13%
Net Earnings / Revenue -114.8% -109.25% -167.49%
Basic Earnings Per Share -$0.33 -$1.37
Diluted Earnings Per Share -$0.33 -$269.0K -$1.37
COMMON SHARES
Basic Shares Outstanding 269.6M shares 45.73M shares
Diluted Shares Outstanding 269.6M shares 45.73M shares

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.618B $1.670B $362.6M
YoY Change 346.14%
Cash & Equivalents $766.1M $1.669B $366.3M
Short-Term Investments $851.4M $374.0K $367.0K
Other Short-Term Assets $51.11M $46.49M $29.89M
YoY Change 70.98%
Inventory
Prepaid Expenses
Receivables $86.87M $101.5M $36.66M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.756B $1.818B $429.1M
YoY Change 309.1% 291.69%
LONG-TERM ASSETS
Property, Plant & Equipment $29.08M $24.92M $36.97M
YoY Change -21.34% 86.33%
Goodwill $108.2M $108.2M
YoY Change
Intangibles $15.13M $15.81M
YoY Change 3263.19%
Long-Term Investments
YoY Change
Other Assets $11.13M $10.70M $28.15M
YoY Change -60.46% 297.29%
Total Long-Term Assets $232.9M $224.5M $190.9M
YoY Change 22.05% 297.37%
TOTAL ASSETS
Total Short-Term Assets $1.756B $1.818B $429.1M
Total Long-Term Assets $232.9M $224.5M $190.9M
Total Assets $1.988B $2.042B $620.0M
YoY Change 220.73% 292.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.93M $9.944M $11.49M
YoY Change 21.17% -15.89%
Accrued Expenses $23.82M $22.66M $34.10M
YoY Change -30.15% 517.19%
Deferred Revenue $196.4M $183.0M
YoY Change 104.09%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $276.7M $281.3M $148.9M
YoY Change 85.81% 118.24%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $19.66M
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $8.039M $6.543M $76.12M
YoY Change -89.44% 1531.67%
Total Long-Term Liabilities $8.039M $6.543M $95.78M
YoY Change -91.61% -67.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $276.7M $281.3M $148.9M
Total Long-Term Liabilities $8.039M $6.543M $95.78M
Total Liabilities $391.2M $391.4M $244.7M
YoY Change 59.87% 77.94%
SHAREHOLDERS EQUITY
Retained Earnings -$711.5M -$621.7M
YoY Change 77.33%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.597B $1.651B -$245.9M
YoY Change
Total Liabilities & Shareholders Equity $1.988B $2.042B $620.0M
YoY Change 220.73% 292.3%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q2
OPERATING ACTIVITIES
Net Income -$89.83M -$71.71M -$62.63M
YoY Change 43.43% 89.5% 135.13%
Depreciation, Depletion And Amortization $2.102M $2.047M $1.659M
YoY Change 26.7% -7.29% -100.02%
Cash From Operating Activities -$49.35M -$5.585M -$30.80M
YoY Change 60.24% -89.8% -99.55%
INVESTING ACTIVITIES
Capital Expenditures $2.808M -$1.773M $780.0K
YoY Change 260.0% -66.8% -99.99%
Acquisitions $0.00 $3.449M
YoY Change -100.0%
Other Investing Activities -$853.0M -$6.000M -$3.449M
YoY Change 24631.55% -99.57%
Cash From Investing Activities -$858.5M -$7.773M -$5.242M
YoY Change 16277.81% 45.56% -100.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $4.904M 17.35M $1.917M
YoY Change 155.82% -93.59% -99.93%
NET CHANGE
Cash From Operating Activities -$49.35M -5.585M -$30.80M
Cash From Investing Activities -$858.5M -7.773M -$5.242M
Cash From Financing Activities $4.904M 17.35M $1.917M
Net Change In Cash -$903.0M 3.990M -$32.83M
YoY Change 2650.11% -98.11% -100.83%
FREE CASH FLOW
Cash From Operating Activities -$49.35M -$5.585M -$30.80M
Capital Expenditures $2.808M -$1.773M $780.0K
Free Cash Flow -$52.16M -$3.812M -$31.58M
YoY Change 65.18% -92.29% -99.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001583708
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-04-30
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 dei Entity File Number
EntityFileNumber
001-40531
CY2022Q2 dei Entity Registrant Name
EntityRegistrantName
SENTINELONE, INC
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0385461
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
444 Castro Street, Suite 400
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Mountain View
CY2022Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
86871000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
101491000 USD
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11132000 USD
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94041
CY2022Q2 dei City Area Code
CityAreaCode
(855)
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
868-3733
CY2022Q2 dei Security12b Title
Security12bTitle
Class A common stock, par value $0.0001
CY2022Q2 dei Trading Symbol
TradingSymbol
S
CY2022Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q2 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q2 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
766101000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1669304000 USD
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
851418000 USD
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
374000 USD
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29083000 USD
CY2022Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
26261000 USD
CY2022Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
27546000 USD
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24849000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
18939000 USD
CY2022Q2 us-gaap Assets Current
AssetsCurrent
1755500000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
1817654000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24918000 USD
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25731000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23884000 USD
CY2022Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
43679000 USD
CY2022Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
41022000 USD
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15130000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15807000 USD
CY2022Q2 us-gaap Goodwill
Goodwill
108193000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
108193000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10703000 USD
CY2022Q2 us-gaap Assets
Assets
1988448000 USD
CY2022Q1 us-gaap Assets
Assets
2042181000 USD
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
13925000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
9944000 USD
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23820000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22657000 USD
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
39654000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
61150000 USD
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2925000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4613000 USD
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
196385000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
182957000 USD
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
276709000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
281321000 USD
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
79259000 USD
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
79062000 USD
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
27199000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24467000 USD
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8039000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6543000 USD
CY2022Q2 us-gaap Liabilities
Liabilities
391206000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
391393000 USD
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-621673000 USD
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1597242000 USD
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2309505000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2271980000 USD
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-783000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
454000 USD
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-711507000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1650788000 USD
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1988448000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2042181000 USD
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78255000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37395000 USD
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
27139000 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
18283000 USD
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-89834000 USD
CY2022Q2 us-gaap Gross Profit
GrossProfit
51116000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
19112000 USD
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45881000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27820000 USD
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
60641000 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
36180000 USD
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34890000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16724000 USD
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
141412000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
80724000 USD
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-90296000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-61612000 USD
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1087000 USD
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
23000 USD
CY2022Q2 us-gaap Interest Expense
InterestExpense
5000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
303000 USD
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-291000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-593000 USD
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-89505000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-62485000 USD
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
329000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
149000 USD
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-89834000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-62634000 USD
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.37
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.37
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
269594565 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
269594565 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45725703 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45725703 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1650788000 USD
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5090000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-62634000 USD
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1237000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
190000 USD
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-91071000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-62444000 USD
CY2022Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2022Q2 s Adjustments To Additional Paid In Capital Early Exercised Options Vested
AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested
18000 USD
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32417000 USD
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1237000 USD
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-89834000 USD
CY2022Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
190000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13560000 USD
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1597242000 USD
CY2021Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
167058113 shares
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
621139000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-320536000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3210000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
120319000 USD
CY2021Q2 s Adjustments To Additional Paid In Capital Early Exercised Options Vested
AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested
17000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-62634000 USD
CY2021Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
167058113 shares
CY2021Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
621139000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-245874000 USD
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-89834000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-62634000 USD
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2102000 USD
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1659000 USD
CY2022Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
7975000 USD
CY2021Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
4375000 USD
CY2022Q2 s Noncash Operating Lease Cost
NoncashOperatingLeaseCost
682000 USD
CY2021Q2 s Noncash Operating Lease Cost
NoncashOperatingLeaseCost
766000 USD
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
31630000 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
13437000 USD
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-288000 USD
CY2021Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
672000 USD
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-14779000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6317000 USD
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5208000 USD
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-257000 USD
CY2022Q2 s Increase Decrease Deferred Contract Acquisition Costs
IncreaseDecreaseDeferredContractAcquisitionCosts
9347000 USD
CY2021Q2 s Increase Decrease Deferred Contract Acquisition Costs
IncreaseDecreaseDeferredContractAcquisitionCosts
5472000 USD
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5079000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2211000 USD
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
190000 USD
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2724000 USD
CY2022Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-21478000 USD
CY2021Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1291000 USD
CY2022Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1330000 USD
CY2021Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-717000 USD
CY2022Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
13626000 USD
CY2021Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
9702000 USD
CY2022Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1495000 USD
CY2021Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
380000 USD
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49351000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30798000 USD
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2808000 USD
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
780000 USD
CY2022Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
152000 USD
CY2021Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2022Q2 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2574000 USD
CY2021Q2 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1013000 USD
CY2022Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
852991000 USD
CY2021Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
CY2022Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2021Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3449000 USD
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-858525000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5242000 USD
CY2022Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
186000 USD
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1826000 USD
CY2022Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5090000 USD
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3743000 USD
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4904000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1917000 USD
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 USD
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1289000 USD
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-902972000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-32834000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1672051000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
399112000 USD
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
769079000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
366278000 USD
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
5000 USD
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
263000 USD
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-184000 USD
CY2021Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-20000 USD
CY2022Q2 s Stock Based Compensation Capitalized As Internal Use Software
StockBasedCompensationCapitalizedAsInternalUseSoftware
787000 USD
CY2021Q2 s Stock Based Compensation Capitalized As Internal Use Software
StockBasedCompensationCapitalizedAsInternalUseSoftware
123000 USD
CY2022Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1277000 USD
CY2021Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
595000 USD
CY2022Q2 s Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
18000 USD
CY2021Q2 s Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
17000 USD
CY2022Q2 s Deferred Offering Costs Accrued But Not Yet Paid
DeferredOfferingCostsAccruedButNotYetPaid
0 USD
CY2021Q2 s Deferred Offering Costs Accrued But Not Yet Paid
DeferredOfferingCostsAccruedButNotYetPaid
1045000 USD
CY2022Q2 us-gaap Stock Issued1
StockIssued1
0 USD
CY2021Q2 us-gaap Stock Issued1
StockIssued1
120319000 USD
CY2022Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. These estimates are based on management’s knowledge about current events and expectations about actions we may undertake in the future. Actual results could differ from these estimates, and such differences could be material to our condensed consolidated financial statements. There have been no material changes in our use of estimates during the three months ended April 30, 2022, as compared to the use of estimates disclosed in our Annual Report on Form 10-K for the fiscal year ended January 31, 2022 filed with the SEC on April 7, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our significant accounting policies as compared to the significant accounting policies described in our Annual Report on Form 10-K filed with the SEC on April 7, 2022.</span></div>
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
766101000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1669304000 USD
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2978000 USD
CY2022Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2747000 USD
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
769079000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1672051000 USD
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78255000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37395000 USD
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78255000 USD
CY2022Q2 s Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
1
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37395000 USD
CY2021Q2 s Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
1
CY2022Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
1800000 USD
CY2021Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
1500000 USD
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
275600000 USD
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
262000000 USD
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
60000000 USD
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
29100000 USD
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
372600000 USD
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.83
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P24M
CY2022Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2021Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
852646000 USD
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000 USD
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1229000 USD
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
851418000 USD
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
0 USD
CY2022 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
0 USD
CY2022Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1642016000 USD
CY2022Q2 s Finite Lived Developed Technology Rights Gross
FiniteLivedDevelopedTechnologyRightsGross
15500000 USD
CY2022Q1 s Finite Lived Developed Technology Rights Gross
FiniteLivedDevelopedTechnologyRightsGross
15500000 USD
CY2022Q2 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
1500000 USD
CY2022Q1 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
1500000 USD
CY2022Q2 us-gaap Finite Lived Noncompete Agreements Gross
FiniteLivedNoncompeteAgreementsGross
650000 USD
CY2022Q1 us-gaap Finite Lived Noncompete Agreements Gross
FiniteLivedNoncompeteAgreementsGross
650000 USD
CY2022Q2 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
150000 USD
CY2022Q1 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
150000 USD
CY2022Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1246000 USD
CY2022Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1094000 USD
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19046000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
18894000 USD
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4171000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3342000 USD
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14875000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15552000 USD
CY2022Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
255000 USD
CY2022Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
255000 USD
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15130000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15807000 USD
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000 USD
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000 USD
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2572000 USD
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2598000 USD
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2373000 USD
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2361000 USD
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2361000 USD
CY2022Q2 s Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
2610000 USD
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14875000 USD
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31630000 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13437000 USD
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.004
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-89834000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-62634000 USD
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
269594565 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
269594565 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45725703 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45725703 shares
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.37
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.37
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
44860274 shares
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
223090004 shares
CY2022Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
500000 USD
CY2021Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
0 USD

Files In Submission

Name View Source Status
0001583708-22-000042-index-headers.html Edgar Link pending
0001583708-22-000042-index.html Edgar Link pending
0001583708-22-000042.txt Edgar Link pending
0001583708-22-000042-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
s-20220430.htm Edgar Link pending
s-20220430.xsd Edgar Link pending
s-20220430_cal.xml Edgar Link unprocessable
s-20220430_def.xml Edgar Link unprocessable
s-20220430_htm.xml Edgar Link completed
s-20220430_lab.xml Edgar Link unprocessable
s-20220430_pre.xml Edgar Link unprocessable
sentinelone10-qex21q123.htm Edgar Link pending
sentinelone10-qex321q123.htm Edgar Link pending
sentinelone10-q_exx311q123.htm Edgar Link pending
sentinelone10-q_exx312q123.htm Edgar Link pending
Show.js Edgar Link pending